Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

OptimizeRx (OPRX) Other Non Operating Income (2019 - 2026)

OptimizeRx's Other Non Operating Income history spans 7 years, with the latest figure at $59000.0 for Q4 2025.

  • On a quarterly basis, Other Non Operating Income rose 51.28% to $59000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $197000.0, a 29.61% increase, with the full-year FY2025 number at $198000.0, up 30.26% from a year prior.
  • Other Non Operating Income hit $59000.0 in Q4 2025 for OptimizeRx, down from $62000.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for OPRX hit a ceiling of $720419.0 in Q2 2023 and a floor of -$1.6 million in Q4 2023.
  • Historically, Other Non Operating Income has averaged $90435.6 across 5 years, with a median of $39000.0 in 2024.
  • The widest YoY moves for Other Non Operating Income: up 22182300.0% in 2023, down 392.3% in 2023.
  • Tracing OPRX's Other Non Operating Income over 5 years: stood at $2382.0 in 2021, then soared by 22507.56% to $538512.0 in 2022, then tumbled by 392.3% to -$1.6 million in 2023, then skyrocketed by 102.48% to $39000.0 in 2024, then soared by 51.28% to $59000.0 in 2025.
  • Business Quant data shows Other Non Operating Income for OPRX at $59000.0 in Q4 2025, $62000.0 in Q3 2025, and $37000.0 in Q2 2025.